PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgery, Penn State College of Medicine, Hershey, Pennsylvania, USA assentongo@pennstatehealth.psu.edu.\', \'Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, USA.\', \'Center for Neural Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA.\', \'Department of Engineering, Science and Mechanics, The Pennsylvania State University, University Park, Pennsylvania, USA.\', \'Department of Surgery, Penn State College of Medicine, Hershey, Pennsylvania, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e00135310.1136/openhrt-2020-001353
?:hasPublicationType
?:journal
  • Open heart
is ?:pmid of
?:pmid
?:pmid
  • 33154144
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.281
?:rankingScore_hIndex
  • 15
is ?:relation_isRelatedTo_publication of
?:title
  • Renin-angiotensin-aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all